Concepedia

Paul Zuck

PZ

Statistics

Publications

34

Citations

1.7K

H-Index

23

Active since

1996

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

WuXi AppTec (United States)

University of Minnesota

Université de Montréal

Paul Zuck is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

MedicineBiochemistryNatural SciencesDrug DiscoveryPharmacologyMolecular BiologyChemical BiologyMedicinal ChemistryBioanalysisSmall Molecules

Publications per year

1996–2023

34

Publications

34

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 411 citations

Natural Sciences, Rna Structure Prediction, Selective Small-molecule Inhibition +3

Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents

Hao Wang, Charles Gill, Sang Hyub Lee et al. · Chemistry & Biology · 2013 · 134 citations · Full text

Medicinal Chemistry, Antimicrobial Drug Discovery, Biochemistry +8

TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci

Sang Ho Lee, Hao Wang, Marc Labroli et al. · Science Translational Medicine · 2016 · 108 citations

Development of an intact cell reporter gene β-lactamase assay for G protein-coupled receptors for high-throughput screening

Priya Kunapuli, Richard W. Ransom, Kathy Murphy et al. · Analytical Biochemistry · 2003 · 84 citations

Signal Transduction, Protein Expression, Biochemistry +10

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

Antonella Converso, Timothy J. Hartingh, R. M. Garbaccio et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 74 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +6

1–5 of 34